These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 1598016)

  • 1. [Seroprevalence of the hepatitis C virus in donors and in high and low risk groups in Salamanca].
    Martín AM; Canut A; Corral M; Cordero M
    Med Clin (Barc); 1992 May; 98(17):676-7. PubMed ID: 1598016
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria.
    Halim NK; Ajayi OI
    East Afr Med J; 2000 Aug; 77(8):410-2. PubMed ID: 12862062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A seroprevalence study of the hepatitis C virus among multiply transfused patients].
    Antipa C; Popescu A; Teleguţă M; Ruţă S; Cernescu C; Târdei G; Copelovici Y; Stoian M; Tivgă N; Hoinărescu M
    Rev Roum Virol; 1993; 44(1-2):9-15. PubMed ID: 8043483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hepatitis C virus among candidates for blood donation at the Hospital General de Mexico.
    Merino-Conde E; Orozco JA; Rojo-Medina J; Tovar A
    In Vivo; 1994; 8(4):621-3. PubMed ID: 7534495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Seroprevalence of hepatitis C virus (HCV) in Senegalease blood donors].
    Dieye TN; Gadji M; Cisse Y; Diallo TA; Toure Falla O; Diop S; Diallo S; Thiam D; Diakhate L
    Dakar Med; 2006; 51(1):47-52. PubMed ID: 16924850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing Hepatitis C virus sero-prevalence among blood donors in north west Pakistan.
    Khattak MN; Akhtar S; Mahmud S; Roshan TM
    J Public Health Policy; 2008 Jul; 29(2):207-25. PubMed ID: 18523475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of hepatitis C virus among blood donors in Rivers State, Nigeria.
    Koate BB; Buseri FI; Jeremiah ZA
    Transfus Med; 2005 Oct; 15(5):449-51. PubMed ID: 16202063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
    Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
    Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in hepatitis B and hepatitis C seroprevalence among Nepalese blood donors.
    Karki S; Ghimire P; Tiwari BR; Maharjan A; Rajkarnikar M
    Jpn J Infect Dis; 2008 Jul; 61(4):324-6. PubMed ID: 18653982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of hepatitis C antibodies in healthy blood donors--a prospective study.
    Bagga PK; Singh SP
    Indian J Pathol Microbiol; 2007 Apr; 50(2):429-32. PubMed ID: 17883101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus seroprevalence rate among Saudis.
    Shobokshi OA; Serebour FE; Al-Drees AZ; Mitwalli AH; Qahtani A; Skakni LI
    Saudi Med J; 2003 Jul; 24 Suppl 2():S81-6. PubMed ID: 12897907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of HIV and hepatitis C co-infection among blood donors in Kathmandu Valley, Nepal.
    Karki S; Ghimire P; Tiwari BR; Shrestha AC; Gautam A; Rajkarnikar M
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):66-70. PubMed ID: 19323036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HCV-positive blood donors. Risk factors].
    Iraporda V; Gil L; Moreda J; Fernández P; González J; Velicia R
    Rev Esp Enferm Dig; 1995 Feb; 87(2):179-80. PubMed ID: 7538317
    [No Abstract]   [Full Text] [Related]  

  • 17. [Seroprevalence of hepatitis C antiviral antibodies in blood donors in N'Djamena (Chad)].
    Massenet D; Djime O
    Bull Soc Pathol Exot; 1993; 86(4):235. PubMed ID: 7507370
    [No Abstract]   [Full Text] [Related]  

  • 18. Prevalence of hepatitis B and C serological markers among first-time blood donors in Brazil: a multi-center serosurvey.
    Nascimento MC; Mayaud P; Sabino EC; Torres KL; Franceschi S
    J Med Virol; 2008 Jan; 80(1):53-7. PubMed ID: 18041005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Seroprevalence of HBV, HCV, and HIV among blood donors in Irapuato, Mexico].
    Carreto-Vélez MA; Carrada-Bravo T; Martínez-Magdaleno A
    Salud Publica Mex; 2003; 45 Supp 5():S690-3. PubMed ID: 14974281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of Hepatitis B and C in the normal population and high risk groups in north Kerala.
    Sandesh K; Varghese T; Harikumar R; Beena P; Sasidharan VP; Bindu CS; Tony J; Harish K; Sunilkumar K; Ramachandran TM
    Trop Gastroenterol; 2006; 27(2):80-3. PubMed ID: 17089617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.